|
|
||||||||


,
Departments of
*
Medicine,
Ophthalmology, and
Pathology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH 44106
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Our studies have focused on determining the molecular mechanisms underlying recruitment of neutrophils and eosinophils into the mammalian cornea in ocular onchocerciasis (river blindness). Using a murine model in which animals are immunized and injected with Ags extracted from the parasitic worm Onchocerca volvulus, we demonstrated that neutrophils and eosinophils infiltrate the cornea and induce severe corneal opacification and neovascularization (2, 3). Since the cornea is an avascular tissue, cellular infiltration originates from limbal vessels in the peripheral region of the cornea, and progresses toward the central cornea where the initial stimulus (injection of parasite Ags) is induced. Because the severity of the clinical response appears to be determined by the number of granulocytes that infiltrate the corneal stroma, identification of essential mediators of recruitment could indicate approaches to immunotherapy. Neutrophil recruitment to the cornea is dependent on expression of the murine IL-8 receptor CXC chemokine receptor 2 (4), whereas eosinophil recruitment is partially dependent on expression of eotaxin (5). Recruitment of both cell types to the cornea is also dependent on development of T cell and Ab responses (3, 6, 7).
Since extravasation from limbal vessels to the corneal stroma is likely to be a critical early event in recruitment of these cells, we examined the relative expression of PECAM-1, ICAM-1, and VCAM-1 on limbal vessels, and determined the role of these adhesion molecules in recruitment of neutrophils and eosinophils to the cornea.
| Materials and Methods |
|---|
|
|
|---|
O. volvulus worms were recovered from s.c. nodules that had been surgically removed from infected patients in Cameroon and kindly sent to us by Dr. Janet Bradley (University of Nottingham, Nottingham, U.K.). Parasites were recovered after digestion with collagenase (Sigma, St. Louis, MO) as described elsewhere (3), and homogenized in HBSS using a mortar and pestle. Insoluble material was removed by centrifugation, and the concentration of protein was determined by standard methods (Bio-Rad, Richmond, CA).
Immunization and intracorneal injections of O. volvulus Ags
C57BL/6 mice were obtained from The Jackson Laboratory (Bar Harbor, ME), and mice deficient in ICAM-1 on a C57BL/6 background (8) were obtained from Dr. Dan Bullard (University of Alabama, Birmingham, AL). Animals were given three weekly s.c. immunizations with 10 µg of O. volvulus Ags in a 1:1 ratio with adjuvant containing 10% squalene (Aldrich, Milwaukee, WI), 0.4% Tween 80 (Fisher, Fair Lawn, NJ), and 1% pluronic acid (BASF Bioresearch, Parsippany, NJ) (3).
For injection into the corneal stroma, mice were anesthetized by i.p. injection of 200 µl of a 1.2% solution of 2,2,2-tribromoethanol (Aldrich) containing 2.5% 2-methyl-2-butanol (tertiary amyl alcohol; Aldrich) dissolved in distilled H2O (9). The corneal epithelial layer was scarified using a 30-gauge needle, and 10 µg of O. volvulus Ags in 5 µl was injected into the corneal stroma using a 33-gauge needle attached to a Hamilton syringe (Hamilton, Reno, NV). All procedures were in accordance with guidelines determined by the Association for Research in Vision and Ophthalmology.
Corneal opacification was graded by slit-lamp examination and evaluated as described previously (3): 0, no pathology, cornea is completely transparent; 1, slight opacity, cornea has discrete areas of opacity, but is mostly transparent; 2, moderate opacity, cornea is mostly opaque, but underlying iris is still visible; and 3, severe opacity, cornea is completely opaque, iris is not visible.
Injections of mAb to PECAM-1, ICAM-1, and VCAM-1 into the subconjunctival space
IgG injected into the conjunctiva diffuses into the corneal stroma (10, 11). To block the activity of adhesion molecules on the vascular endothelium, 25 µg of anti-PECAM-1 (rat IgG2a, MEC 13.3; PharMingen, San Diego, CA), anti-ICAM-1 (rat IgG2a, KAT-1; Caltag Laboratories, Burlingame, CA), or anti-VCAM-1 (rat IgG1, M/K-2; Caltag Laboratories) Ab in 5 µl was injected into the subconjunctival space of the right eye, and 25 µg of control rat IgG (Sigma) was injected into the left subconjunctival space. Injections were performed using a 33-gauge needle attached to a Hamilton syringe. Subconjunctival injections were repeated 24 and 48 h later.
To detect in vivo-injected Abs binding to the limbal vascular endothelium, eyes were snap-frozen and sections were incubated directly with FITC-conjugated anti-rat IgG (Caltag Laboratories). Positively stained vessels were visualized by fluorescence microscopy.
Detection of neutrophils and eosinophils
Enucleated eyes were fixed overnight in 10% formaldehyde (Sigma) in distilled H2O, processed by standard methods, and embedded in paraffin. Sections (5 µm) were immunostained with rabbit antisera to major basic protein to detect eosinophils as described previously (6, 12). Biotinylated goat anti-rabbit Ig (Dako, Carpinteria, CA) was used as the secondary Ab. Neutrophils were detected using the rat mAb NIMP-R14 diluted 1/100, followed by biotinylated rabbit anti-rat Ig (BioGenex, San Ramon, CA). Sections were then incubated with alkaline phosphatase-conjugated streptavidin (Dako), and positively stained cells were visualized using Vector Red substrate containing levamisole (Vector Laboratories, Burlingame, CA). Sections were counterstained with modified Harris hematoxylin (Richard-Allen, Kalamazoo, MI) and examined by bright-field and fluorescence microscopy. Total neutrophils and eosinophils per section were determined by direct counting.
For immunostaining of vascular adhesion molecules, eyes were snap-frozen in liquid nitrogen, stored at -70°C, and 5-µm sections were air dried overnight and stored at -20°C. Sections were fixed for 10 min in -20°C acetone. Slides were air dried and rehydrated in PBS (pH 7.4). Adjacent sections on the same slide were stained with rat mAb against either PECAM-1 (MEC 13.3), ICAM-1 (KAT-1), or VCAM-1 (M/K-2). Primary Abs were diluted 1:100 in PBS containing 1% FCS and incubated for 2 h at room temperature. FITC-conjugated anti-rat IgG (H + L; Caltag Laboratories) diluted 1/100 was used as a secondary Ab and incubated for 45 min. Stained sections were washed in PBS and coverslipped with Vectashield Mounting Medium (Vector Laboratories) to inhibit quenching.
Evaluation of staining intensity
Evaluation of expression of FITC-stained adhesion molecules on limbal vessels was based on the method described by Tang and Hendricks (13) for detection of PECAM. After immunostaining for PECAM-1, ICAM-1, and VCAM-1, images of limbal vessels were captured using a digital camera model DC330 (PAGE-MTI, Michigan City, IN) and Scion Image Software (version 1.62c; National Institutes of Health, Bethesda, MD, modified by Scion Corp.). To evaluate the relative fluorescence intensity, the mean brightness value of the green channel of the three most intensely stained areas of the vessel was determined using Adobe Photoshop 5.0 (Adobe Systems, San Jose, CA) with a set 400 pixel square area. Four vessels from each eye were analyzed, the background reading in unstained areas of the cornea was subtracted from these values, and the mean ± SE of the fluorescence intensity for each vessel was estimated. Data are then presented as the percent maximum value for each Ab.
Statistics
Statistical significance was determined using an unpaired Students t test (Prism GraphPad Software, San Diego, CA). A value of p < 0.05 was considered to be significant.
| Results |
|---|
|
|
|---|
O. volvulus keratitis was induced in mice after s.c. immunization and subsequent injection of parasite Ags into the corneal stroma. To determine the relative expression of PECAM-1, ICAM-1, and VCAM-1 on limbal vessels, C57BL/6 mice were sacrificed either immediately after injection of O. volvulus Ags into the corneal stroma (0 h) or after 12 h, 24 h, 72 h, or 7 days (168 h). Eyes were enucleated, and 5-µm sections were immunostained with mAb for PECAM-1, ICAM-1, and VCAM-1.
Fig. 1
A (upper
panels) shows representative corneas from each time point and
demonstrates expression of PECAM-1, ICAM-1, and VCAM-1 on adjacent
sections of the same limbal vessels. Although expression of each of
these molecules was elevated after intrastromal injection, there were
at least two distinct features: first, PECAM-1 was expressed
immediately after injection (0 h), whereas ICAM-1 and VCAM-1 were not
detected. Second, compared with PECAM-1 and ICAM-1, VCAM-1 expression
was transient, being elevated at 72 h after injection, and
decreasing by day 7. Corneas from naive mice reacted with Ab to PECAM-1
at a similar level to 0 h and did not react with Ab to ICAM-1 or
VCAM-1 (data not shown).
|
Neutrophil recruitment to the cornea is dependent on expression of PECAM-1
To determine whether PECAM-1 expression has a role in neutrophil or eosinophil migration to the cornea in O. volvulus keratitis, anti-PECAM-1 mAb was injected into the subconjunctival space of immunized C57BL/6 mice before injection of O. volvulus Ags into the corneal stroma. Control rat IgG was injected into the subconjunctival space of the contralateral eye. Mice were sacrificed 24 or 72 h later, corneas were immunostained to detect neutrophils and eosinophils, and the number of cells in the corneal stroma was determined by direct counting.
Ab injected into the subconjunctival space has been shown to modulate
immune and inflammatory responses in the cornea (10, 11).
To determine whether subconjunctival injection of rat Ab to PECAM-1
reacted with limbal vessels, eyes were removed 24 or 72 h after
intrastromal injection, and corneas were stained directly with
secondary FITC anti-rat IgG. As shown in Fig. 2
, upper panels,
anti-PECAM-1 bound to limbal vessels, whereas no Ab was detected
after injection of control rat IgG.
|
Consistent with this observation, neutrophil recruitment was
significantly impaired 24 h after injection (p
= 0.012; Fig. 2
). To determine whether PECAM-1 is also important for
eosinophil infiltration, mice were injected with anti-PECAM-1 24
and 48 h later, and the number of eosinophils at 72 h was
determined by direct counting. In contrast to neutrophils, eosinophil
migration to the cornea was not inhibited after injection of
anti-PECAM-1 (Fig. 2
, lower panel). Neutrophils were not
detected at 72 h in either group, indicating that the PECAM-1
blockade was not simply delaying infiltration of these cells.
PECAM-1 is essential for development of corneal opacification in O. volvulus keratitis
Since the presence of neutrophils and eosinophils is associated
with loss of corneal clarity in O. volvulus keratitis, we
also examined the effect of blockade of these adhesion molecules on the
development of corneal opacification. As shown in Fig. 3
, corneas of control mice develop
significant opacification scores by day 1, coinciding with neutrophil
infiltration. Consistent with decreased neutrophil emigration to the
cornea in anti-PECAM-1-injected eyes, we found that corneal
opacification was significantly reduced after PECAM-1 blockade compared
with control corneas (p < 0.0001). There was
no significant difference on day 3, when eosinophils were the
predominant cell type present.
|
To determine the effect of ICAM-1 blockade on neutrophil and eosinophil recruitment to the cornea, anti-ICAM-1 mAb was injected into the subconjunctival space before intrastromal injection of parasite Ags and normal rat IgG was injected into contralateral eyes. Animals were sacrificed 24 or 72 h later, and the number of neutrophils and eosinophils in the cornea was assessed.
As shown in Fig. 4
, upper
panels, anti-ICAM-1 Ab bound to limbal vessels after
subconjunctival injection. In contrast to PECAM-1, ICAM-1 blockade had
no effect on neutrophil infiltration (Fig. 4
, center panel).
However, eosinophil recruitment was significantly inhibited compared
with control eyes (p = 0.0032, Fig. 4
, lower panel).
|
Although neutrophil recruitment in ICAM-1-/- mice was not significantly different from control animals (C57BL/6: 1047 ± 141.2, n = 5; ICAM-1-/-: 938.6 ± 92.25, n = 5; p = 0.3393), eosinophil infiltration was significantly impaired (C57BL/6: 482.2 ± 141.2 (SEM), n = 5; ICAM-1-/-: 93.0 ± 21.64, n = 5; p = 0.0465). There was no significant difference in corneal opacification after blockade of ICAM-1 or in ICAM-1-/- mice (data not shown). This finding may be due to incomplete blockade of eosinophil infiltration to the cornea, as there were 62% fewer eosinophils in the cornea after subconjunctival injection of anti-ICAM-1 and 80.7% fewer eosinophils in ICAM-1-/- mice.
Taken together with the observations on local ICAM-1 blockade, these data indicate that ICAM-1 expressed on the limbal vessels has a selective role in eosinophil transmigration to the corneal stroma.
VCAM-1 blockade does not inhibit neutrophil or eosinophil recruitment
To determine whether VCAM-1 expression contributes to neutrophil and eosinophil emigration to the corneal stroma, mAb against VCAM-1 were injected into the subconjunctival space of immunized C57Bl/6 before intrastromal injection of O. volvulus Ags. Eyes were enucleated 24 or 72 h after injection of helminth Ags, and the number of neutrophils and eosinophils in the corneal stroma was determined as described earlier.
Fig. 5
shows that although Ab to VCAM-1
bound to limbal vessels, neutrophil and eosinophil recruitment to the
corneal stroma was not significantly inhibited in comparison to rat
IgG-injected eyes. Consistent with this finding, there was no
significant difference in corneal opacification after blockade of
VCAM-1 compared with controls (data not shown).
|
| Discussion |
|---|
|
|
|---|
If the cornea is subjected to trauma or infection, leukocytes infiltrate from limbal vessels toward the site of injury. Although inflammatory cells are important in host defense, they can also have a cytotoxic effect on resident cells in the cornea, resulting in loss of corneal transparency, visual impairment, and possibly blindness. Furthermore, although anti-inflammatory mechanisms are in place in the eye to maintain immune privilege, including expression of Fas ligand (15), intense inflammatory responses that cause clinical damage can still occur.
In onchocerciasis (river blindness), heavy invasion of parasitic worms into the cornea induces peripheral opacification, which progresses centrally to obscure the entire cornea (16). Epidemiological evidence indicates that corneal inflammation is initiated after death and degeneration of the worms and subsequent release of somatic Ags into the corneal stroma (17). In the murine model of ocular onchocerciasis described here, the inflammatory response is initiated after O. volvulus Ags are injected directly into the corneal stroma of sensitized animals.
Results obtained using this model are consistent with
theproposed sequence of events outlined in Fig. 6
. Subcutaneous immunization with
O. volvulus Ags stimulates a predominant Th2 response, with
elevated IL-4, IL-5, eosinophilia, and parasite-specific Ab, especially
IgG1 (3, 6). After injection of parasite Ags into the
cornea, neutrophils and eosinophils are recruited to the stroma where
degranulation and release of cytotoxic mediators such as eosinophil
cationic proteins disrupts the normal function of the cornea, leading
to loss of corneal clarity and visual impairment. Ab appears to
contribute by forming immune complexes that mediate degranulation
(3).
|
Our findings that PECAM-1 mediates neutrophil extravasation from limbal
vessels are consistent with those of Tang and Hendricks
(13), who demonstrated that PECAM-1 expression mediates
neutrophil recruitment to the cornea in herpes simplex keratitis and
that both are regulated by IFN-
. PECAM-1 is also important in
neutrophil infiltration to other tissues, including the lungs and
peritoneal cavity (20, 21, 22, 23). Furthermore, anti-PECAM-1
Ab can block intradermal accumulation of neutrophils to human skin
transplanted onto SCID mice (23, 24). In addition to
neutrophils, PECAM-1 is expressed on monocytes, T cells, and platelets.
To the best of our knowledge, PECAM-1 has not been shown to directly
mediate transmigration of eosinophils, although in vitro studies with
IL-4-stimulated HUVECs indicate that CD31 indirectly enhances
integrin-mediated interactions with eosinophils (25).
In contrast to ICAM-1 and VCAM-1, PECAM-1 mediates leukocyte passage through the basement membrane and has no apparent effect on rolling or adhesion (26, 27). However, PECAM-1 mediates leukocyte transmigration across the endothelial cell layer and passage through the basement membrane, interactions that are dependent on the amino terminal and the membrane proximal regions of the extracellular domain of PECAM-1, respectively (28). Transendothelial migration is also dependent on homophilic interactions between PECAM-1 on leukocytes and PECAM-1 on endothelial cells (22, 24, 26, 28). As neutrophils express PECAM-1 (22) it is likely that homophilic interactions are involved in neutrophil recruitment to the cornea and that mAb to PECAM-1 binds neutrophils and vascular endothelium, leading to blockade of this interaction.
Neutrophils also express LFA-1, which is a ligand for ICAM-1, and ICAM-1 interactions mediate neutrophil migration to other tissues, including the skin and peritoneal cavity (8, 29). Interestingly, in the murine model of Pseudomonas aeruginosa keratitis, ICAM-1-deficient mice had significantly fewer neutrophils in the cornea and anterior chamber (30). The differences between those findings and results of the current study, where neither injection of anti-ICAM-1 nor ICAM-1 deficiency had any significant effect on neutrophil recruitment to the cornea, have yet to be determined. In contrast to neutrophils, the role of ICAM-1 expression in eosinophil extravasation is consistent with expression of LFA-1 ligand on eosinophils (31, 32) and with reports in which ICAM-1 blockade inhibits the migration of eosinophils to the skin and the airways (33, 34).
A surprising finding was that VCAM-1 blockade had no effect on eosinophil recruitment to the cornea, despite elevated expression coinciding with maximal eosinophil numbers in the cornea. Either VCAM-1 has no role in this experimental model or other adhesion molecules such as ICAM-1 and P-selectin compensate when VCAM-1 activity is blocked. The absence of an effect is not likely to be due to ineffectiveness of the Ab, as M/K-2 inhibits cardiac allograft rejection (35). Future studies will examine the role of VCAM-1 in the context of ICAM-1 and P-selectin depletion.
Eosinophils express very late Ag 4 and eosinophil transmigration across HUVECs is dependent on VCAM-1, especially after exposure to IL-4 (36, 37). VCAM-1 blockade also inhibits IL-4-dependent eosinophil accumulation in the dermis (38). IL-4 is elevated in the cornea in O. volvulus keratitis (3, 38), and local production of IL-4 may explain the difference between our findings and those of Zhu and Dana (29), who demonstrated expression of ICAM-1 and PECAM-1 on limbal vessels, but did not show VCAM-1 expression. Future studies will examine the role of IL-4 and other immunoregulatory cytokines on expression of adhesion molecules on limbal vessels.
In conclusion, results of this study demonstrate a role for PECAM-1 and ICAM-1 in recruitment of neutrophils and eosinophils, respectively, to the corneal stroma. Blockade of vascular adhesion molecule interactions along with chemokine receptor interactions may indicate a feasible approach to immunotherapy in corneal disease, since granulocyte infiltration can be inhibited without affecting systemic responses.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Eric Pearlman, Division of Geographic Medicine, Case Western Reserve University School of Medicine, W137, 2109 Adelbert Road, Cleveland, OH 44106. E-mail address: exp2{at}po.cwru.edu ![]()
3 Abbreviation used in this paper: PECAM-1, platelet endothelial cell adhesion molecule 1. ![]()
Received for publication January 18, 2001. Accepted for publication March 29, 2001.
| References |
|---|
|
|
|---|
regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J. Exp. Med. 184:1435.
v
3 integrin and enhances
1 integrin-mediated adhesion of eosinophils to endothelial cells. Blood 94:1319.
and
4 integrin/VCAM-1 adhesion pathways. J. Immunol. 160:5637.This article has been cited by other articles:
![]() |
S. E. Byeseda, A. R. Burns, S. Dieffenbaugher, R. E. Rumbaut, C. W. Smith, and Z. Li ICAM-1 Is Necessary for Epithelial Recruitment of {gamma}{delta} T Cells and Efficient Corneal Wound Healing Am. J. Pathol., August 1, 2009; 175(2): 571 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gentil and E. Pearlman Gamma Interferon and Interleukin-1 Receptor 1 Regulate Neutrophil Recruitment to the Corneal Stroma in a Murine Model of Onchocerca volvulus Keratitis Infect. Immun., April 1, 2009; 77(4): 1606 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gillette-Ferguson, K. Daehnel, A. G. Hise, Y. Sun, E. Carlson, E. Diaconu, H. F. McGarry, M. J. Taylor, and E. Pearlman Toll-Like Receptor 2 Regulates CXC Chemokine Production and Neutrophil Recruitment to the Cornea in Onchocerca volvulus/ Wolbachia-Induced Keratitis Infect. Immun., December 1, 2007; 75(12): 5908 - 5915. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, A. R. Burns, and C. W. Smith Lymphocyte Function-Associated Antigen-1-Dependent Inhibition of Corneal Wound Healing Am. J. Pathol., November 1, 2006; 169(5): 1590 - 1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Semnani, P. B. Keiser, Y. I. Coulibaly, F. Keita, A. A. Diallo, D. Traore, D. A. Diallo, O. K. Doumbo, S. F. Traore, J. Kubofcik, et al. Filaria-Induced Monocyte Dysfunction and Its Reversal following Treatment. Infect. Immun., August 1, 2006; 74(8): 4409 - 4417. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Carlson, J. Drazba, X. Yang, and V. L. Perez Visualization and Characterization of Inflammatory Cell Recruitment and Migration through the Corneal Stroma in Endotoxin-Induced Keratitis Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 241 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. McInnis, A. Britain, R. N. Lausch, and J. E. Oakes Synthesis of {alpha}-Chemokines IP-10, I-TAC, and MIG Are Differentially Regulated in Human Corneal Keratocytes Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1668 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Pereira, X. Ruan, M. L. Gonzalez, I. Tsyshevskaya-Hoover, and J. Chodosh Modulation of Corneal Epithelial Cell Functions by the Neutrophil-Derived Inflammatory Mediator CAP37 Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4284 - 4292. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gillette-Ferguson, A. G. Hise, H. F. McGarry, J. Turner, A. Esposito, Y. Sun, E. Diaconu, M. J. Taylor, and E. Pearlman Wolbachia-Induced Neutrophil Activation in a Mouse Model of Ocular Onchocerciasis (River Blindness) Infect. Immun., October 1, 2004; 72(10): 5687 - 5692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Hise, I. Gillette-Ferguson, and E. Pearlman Immunopathogenesis of Onchocerca volvulus keratitis (river blindness): a novel role for TLR4 and endosymbiotic Wolbachia bacteria Innate Immunity, December 1, 2003; 9(6): 390 - 394. [Abstract] [PDF] |
||||
![]() |
R. T. Semnani, A. Y. Liu, H. Sabzevari, J. Kubofcik, J. Zhou, J. K. Gilden, and T. B. Nutman Brugia malayi Microfilariae Induce Cell Death in Human Dendritic Cells, Inhibit Their Ability to Make IL-12 and IL-10, and Reduce Their Capacity to Activate CD4+ T Cells J. Immunol., August 15, 2003; 171(4): 1950 - 1960. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Denkinger, M. Denkinger, J. J. Kort, C. Metz, and T. G. Forsthuber In Vivo Blockade of Macrophage Migration Inhibitory Factor Ameliorates Acute Experimental Autoimmune Encephalomyelitis by Impairing the Homing of Encephalitogenic T Cells to the Central Nervous System J. Immunol., February 1, 2003; 170(3): 1274 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hoerauf, D. W Buttner, O. Adjei, and E. Pearlman Science, medicine, and the future: Onchocerciasis BMJ, January 25, 2003; 326(7382): 207 - 210. [Full Text] [PDF] |
||||
![]() |
T. H. Wyman, A. J. Bjornsen, D. J. Elzi, C. W. Smith, K. M. England, M. Kelher, and C. C. Silliman A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release Am J Physiol Cell Physiol, December 1, 2002; 283(6): C1592 - C1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Berger, N. M. Blackwell, J. H. Lass, E. Diaconu, and E. Pearlman IL-4 and IL-13 Regulation of ICAM-1 Expression and Eosinophil Recruitment in Onchocerca volvulus Keratitis Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2992 - 2997. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khatri, J. H. Lass, F. P. Heinzel, W. M. Petroll, J. Gomez, E. Diaconu, C. M. Kalsow, and E. Pearlman Regulation of Endotoxin-Induced Keratitis by PECAM-1, MIP-2, and Toll-like Receptor 4 Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2278 - 2284. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Broide Fast Flowing Eosinophils . Signals for Stopping and Stepping Out of Blood Vessels Am. J. Respir. Cell Mol. Biol., June 1, 2002; 26(6): 637 - 640. [Full Text] [PDF] |
||||
![]() |
B. Trudinger, J. Wang, N. Athayde, L. Beutler, and X. Wang Association of Umbilical Placental Vascular Disease With Fetal Acute Inflammatory Cytokine Responses Reproductive Sciences, May 1, 2002; 9(3): 152 - 157. [Abstract] [PDF] |
||||
![]() |
A. v. S. Andre, N. M. Blackwell, L. R. Hall, A. Hoerauf, N. W. Brattig, L. Volkmann, M. J. Taylor, L. Ford, A. G. Hise, J. H. Lass, et al. The Role of Endosymbiotic Wolbachia Bacteria in the Pathogenesis of River Blindness Science, March 8, 2002; 295(5561): 1892 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. MacDonald, M. I. Araujo, and E. J. Pearce Immunology of Parasitic Helminth Infections Infect. Immun., February 1, 2002; 70(2): 427 - 433. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |